Showing results (231-240 of 697) with videos related to

Sort By:
Pageof 70
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 25, 1999
Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089B L Lokeshwar, G G Schwartz, M G Selzer, et al.
The New England Journal of Medicine|August 8, 1991
A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarctionM J Stampfer, F M Sacks, S Salvini, et al.
Atherosclerosis|June 15, 2015
Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humansNirav K Desai, Esther M Ooi, Paul D Mitchell, et al.
American Journal of Veterinary Research|March 1, 1989
Complement, bacteriostatic, and enzymatic activities in sera from guinea pigs given aflatoxin and/or rubratoxinJ R Thurston, J M Sacks, J L Richard, et al.
Plastic and Reconstructive Surgery|March 21, 2022
The Price of Publishing: An Investigation of the Open Access Landscape in Plastic SurgeryPooja S Yesantharao, Chao Long, Justin M Sacks, et al.
The American Journal of Cardiology|September 28, 1995
The influence of pretreatment low density lipoprotein cholesterol concentrations on the effect of hypocholesterolemic therapy on coronary atherosclerosis in angiographic trials. Harvard Atherosclerosis Reversibility Project Research GroupF M Sacks, C M Gibson, B Rosner, et al.
Circulation|October 12, 2011
Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart diseaseCarlos O Mendivil, Eric B Rimm, Jeremy Furtado, et al.
The American Journal of Psychiatry|March 1, 1994
Undetected HIV infection among patients admitted to an alcohol rehabilitation unitJ Mahler, D Yi, M Sacks, et al.
Journal of the American College of Cardiology|February 1, 1995
A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physiciansE Guallar, C H Hennekens, F M Sacks, et al.
Plos One|April 8, 2014
Plasma pentraxin 3 levels do not predict coronary events but reflect metabolic disorders in patients with coronary artery disease in the CARE trialTetsuro Miyazaki, Stephanie Chiuve, Frank M Sacks, et al.
Pageof 70